Integer (NYSE:ITGR) Stock Rating Lowered by Oppenheimer

Oppenheimer cut shares of Integer (NYSE:ITGR - Free Report) from an outperform rating to a market perform rating in a research note released on Friday morning, MarketBeat reports.

A number of other research firms also recently weighed in on ITGR. Citigroup lifted their price objective on Integer from $130.00 to $145.00 and gave the company a "neutral" rating in a report on Wednesday, December 11th. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $160.00 price target on shares of Integer in a research note on Tuesday, December 3rd. Piper Sandler reiterated an "overweight" rating and set a $140.00 price objective (up from $125.00) on shares of Integer in a research note on Friday, October 25th. KeyCorp boosted their target price on shares of Integer from $144.00 to $154.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Finally, Truist Financial increased their target price on shares of Integer from $147.00 to $163.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th. Two equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $147.67.

Integer Stock Performance

Shares of NYSE:ITGR traded up $1.09 during trading on Friday, hitting $128.07. 472,349 shares of the stock were exchanged, compared to its average volume of 265,979. The company has a market capitalization of $4.31 billion, a price-to-earnings ratio of 38.12, a price-to-earnings-growth ratio of 1.72 and a beta of 1.13. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. Integer has a 1-year low of $102.14 and a 1-year high of $146.36. The company's fifty day simple moving average is $137.51 and its 200-day simple moving average is $132.81.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing analysts' consensus estimates of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The business had revenue of $449.50 million for the quarter, compared to analyst estimates of $446.28 million. Sell-side analysts expect that Integer will post 6.01 EPS for the current fiscal year.

Hedge Funds Weigh In On Integer

Several hedge funds have recently added to or reduced their stakes in ITGR. Capital Research Global Investors increased its stake in Integer by 16.0% in the fourth quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider's stock valued at $186,960,000 after purchasing an additional 194,895 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Integer by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider's stock valued at $99,408,000 after buying an additional 9,421 shares during the period. Loomis Sayles & Co. L P increased its position in shares of Integer by 3.8% in the 4th quarter. Loomis Sayles & Co. L P now owns 558,715 shares of the medical equipment provider's stock valued at $74,041,000 after buying an additional 20,688 shares in the last quarter. Congress Asset Management Co. raised its stake in Integer by 2.0% during the 4th quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider's stock worth $66,041,000 after buying an additional 9,565 shares during the period. Finally, Driehaus Capital Management LLC lifted its holdings in Integer by 5.5% during the fourth quarter. Driehaus Capital Management LLC now owns 451,464 shares of the medical equipment provider's stock worth $59,828,000 after acquiring an additional 23,706 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.